These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 34801106)

  • 1. CoronaVac efficacy data from Turkey - Authors' reply.
    Tanriover MD; Doğanay HL; Unal S; Akova M
    Lancet; 2021 Nov; 398(10314):1874. PubMed ID: 34801106
    [No Abstract]   [Full Text] [Related]  

  • 2. CoronaVac efficacy data from Turkey.
    McMenamin ME; Cowling BJ
    Lancet; 2021 Nov; 398(10314):1873-1874. PubMed ID: 34801104
    [No Abstract]   [Full Text] [Related]  

  • 3. SARS-CoV-2 specific antibody responses after third CoronaVac or BNT162b2 vaccine following two-dose CoronaVac vaccine regimen.
    Keskin AU; Bolukcu S; Ciragil P; Topkaya AE
    J Med Virol; 2022 Jan; 94(1):39-41. PubMed ID: 34536028
    [No Abstract]   [Full Text] [Related]  

  • 4. Should a third booster dose be scheduled after two doses of CoronaVac? A single-center experience.
    Yigit M; Ozkaya-Parlakay A; Cosgun Y; Ince YE; Bulut YE; Senel E
    J Med Virol; 2022 Jan; 94(1):287-290. PubMed ID: 34487373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine.
    Melo-González F; Soto JA; González LA; Fernández J; Duarte LF; Schultz BM; Gálvez NMS; Pacheco GA; Ríos M; Vázquez Y; Rivera-Pérez D; Moreno-Tapia D; Iturriaga C; Vallejos OP; Berríos-Rojas RV; Hoppe-Elsholz G; Urzúa M; Bruneau N; Fasce RA; Mora J; Grifoni A; Sette A; Weiskopf D; Zeng G; Meng W; González-Aramundiz JV; González PA; Abarca K; Ramírez E; Kalergis AM; Bueno SM
    Front Immunol; 2021; 12():747830. PubMed ID: 34858404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralization of alpha, gamma, and D614G SARS-CoV-2 variants by CoronaVac vaccine-induced antibodies.
    Fernández J; Bruneau N; Fasce R; Martín HS; Balanda M; Bustos P; Ulloa S; Mora J; Ramírez E
    J Med Virol; 2022 Jan; 94(1):399-403. PubMed ID: 34460119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boosting immunity after CoronaVac.
    Sester M; Becker SL
    Lancet; 2022 Feb; 399(10324):496-497. PubMed ID: 35074137
    [No Abstract]   [Full Text] [Related]  

  • 8. CoronaVac: more data for regulators and policy makers.
    Ramasamy MN; Jessop LJ
    Lancet; 2021 Jul; 398(10296):186-188. PubMed ID: 34246359
    [No Abstract]   [Full Text] [Related]  

  • 9. Limited and Short-Lasting Virus Neutralizing Titers Induced by Inactivated SARS-CoV-2 Vaccine.
    Hunsawong T; Fernandez S; Buathong R; Khadthasrima N; Rungrojchareonkit K; Lohachanakul J; Suthangkornkul R; Tayong K; Huang AT; Klungthong C; Chinnawirotpisan P; Poolpanichupatam Y; Jones AR; Lombardini ED; Wacharapluesadee S; Putcharoen O
    Emerg Infect Dis; 2021 Dec; 27(12):3178-3180. PubMed ID: 34559045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines.
    Chan RWY; Liu S; Cheung JY; Tsun JGS; Chan KC; Chan KYY; Fung GPG; Li AM; Lam HS
    Front Immunol; 2021; 12():744887. PubMed ID: 34712232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity, safety and reactogenicity of a heterogeneous booster following the CoronaVac inactivated SARS-CoV-2 vaccine in patients with SLE: a case series.
    Assawasaksakul T; Sathitratanacheewin S; Vichaiwattana P; Wanlapakorn N; Poovorawan Y; Kittanamongkolchai W
    RMD Open; 2021 Dec; 7(3):. PubMed ID: 34862313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigation of the seroprevalence of CrimeanCongo Hemorrhagic Fever and Lumpy Skin Disease in domesticated water buffaloes in northern Turkey.
    Okur-Gumusova S; Tamer C; Ozan E; Cavunt A; Kadi H; Muftuoglu B; Eisa Elhag A; Yazici Z; Albayrak H
    Trop Biomed; 2020 Mar; 37(1):165-173. PubMed ID: 33612727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. West nile virus infection in the Mesopotamia region, Syria border of Turkey.
    Karakoç ZÇ; Tüzüner BM; Ergonul O; Pierro A; Di Fonzo E; Koruk İ; Sambri V
    Vector Borne Zoonotic Dis; 2013 Oct; 13(10):739-43. PubMed ID: 23808974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity after two doses of inactivated virus vaccine in healthcare workers with and without previous COVID-19 infection: Prospective observational study.
    Yalçın TY; Topçu DI; Doğan Ö; Aydın S; Sarı N; Erol Ç; Kuloğlu ZE; Azap ÖK; Can F; Arslan H
    J Med Virol; 2022 Jan; 94(1):279-286. PubMed ID: 34468990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stablity of yellow fever virus neutralising antibody titres - Authors' reply.
    Domingo C; Bhat N; Ansah P; Mejía JE
    Lancet Infect Dis; 2020 Feb; 20(2):167. PubMed ID: 32006502
    [No Abstract]   [Full Text] [Related]  

  • 16. A DNA prime-protein boost vaccination strategy targeting turkey coronavirus spike protein fragment containing neutralizing epitope against infectious challenge.
    Chen YN; Wu CC; Yeo Y; Xu P; Lin TL
    Vet Immunol Immunopathol; 2013 Apr; 152(3-4):359-69. PubMed ID: 23428360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sandfly fever virus activity in central/northern Anatolia, Turkey: first report of Toscana virus infections.
    Ergünay K; Saygan MB; Aydoğan S; Lo MM; Weidmann M; Dilcher M; Sener B; Hasçelik G; Pınar A; Us D
    Clin Microbiol Infect; 2011 Apr; 17(4):575-81. PubMed ID: 20731683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal Antibody for Patients with Covid-19. Reply.
    Lundgren JD; Lane HC; Neaton JD
    N Engl J Med; 2021 Mar; 384(12):1171. PubMed ID: 33534968
    [No Abstract]   [Full Text] [Related]  

  • 19. Neutralization interfering antibodies: a "novel" example of humoral immune dysfunction facilitating viral escape?
    Nicasio M; Sautto G; Clementi N; Diotti RA; Criscuolo E; Castelli M; Solforosi L; Clementi M; Burioni R
    Viruses; 2012 Sep; 4(9):1731-52. PubMed ID: 23170181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breakthrough COVID-19 case after full-dose administration of CoronaVac vaccine.
    Ulhaq ZS; Soraya GV; Indriana K
    Indian J Med Microbiol; 2021; 39(4):562-563. PubMed ID: 34099338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.